Actavis is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Through operations in approximately 100 countries, we are focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.
The Actavis Global Supply Chain features 40 manufacturing and distribution facilities around the world, and includes Anda, Inc., a leading U.S. pharmaceutical product distributor. Additionally, Actavis develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.